A liver transplant might save him — if he can get the drug he needs to stay alive long enough

In a clinical trial from the drugmaker, 62 patients with cholangiocarcinoma got Ziihera. In order to be included in the trial, patients could not have previously taken a HER2 drug for their cancer.

Cigna’s denials, however, said Middleton could…